Scintilla Bio-Marc Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-05-2024
- Paid Up Capital ₹ 0.57 M
as on 15-05-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 15-05-2024
- Revenue -41.37%
(FY 2017)
- Profit 32.78%
(FY 2017)
- Ebitda -41.34%
(FY 2017)
- Net Worth -13.56%
(FY 2017)
- Total Assets -31.80%
(FY 2017)
About Scintilla Bio-Marc
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.57 M.
The company currently has active open charges totaling ₹5.00 M.
Sanyasihally Nagendra, Divya, and Chandrashekar Kattaya serve as directors at the Company.
- CIN/LLPIN
U85100KA2011PTC057698
- Company No.
057698
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Scintilla Bio-Marc?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya  | Director | 26-Jun-2020 | Current |
Sanyasihally Nagendra  | Director | 01-Feb-2012 | Current |
| Chandrashekar Kattaya | Director | 18-Mar-2011 | Current |
Financial Performance of Scintilla Bio-Marc.
Scintilla Bio-Marc Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 41.37% decrease. The company also saw a substantial improvement in profitability, with a 32.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scintilla Bio-Marc?
In 2017, Scintilla Bio-Marc had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Green Stone Projects & Estates Private LimitedActive 16 years 9 monthsChandrashekar Kattaya is a mutual person
- Prospace Design Consultants Private LimitedActive 13 years 4 months
Chandrashekar Kattaya is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Vijaya Bank Creation Date: 06 May 2013 | ₹5.00 M | Open |
How Many Employees Work at Scintilla Bio-Marc?
Unlock and access historical data on people associated with Scintilla Bio-Marc, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scintilla Bio-Marc, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scintilla Bio-Marc's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
